Dental Associate Buy-In: How Equity Deal Structures Actually Work

An associate buy-in is four decisions, not one: what you're buying (stock or LLC units), what price the stake is set at, how you pay for it, and what happens when the partnership ends badly. Most deals that blow up were priced fine. They fell apart on the last two. So before you talk multiples with your senior partner, get clear on the structure, because the structure determines whether you're a partner or a well-paid associate holding a certificate.

Here's the short version. Equity in a dental practice is worth a multiple of adjusted EBITDA, and that multiple scales with practice size, not with how long you've worked there. Banks will fund the purchase, but they want real cash down, typically 20 to 25 percent of the price. Your equity almost certainly vests over five years with a one-year cliff, and if you're terminated "for cause," the buyback clause probably pays you less than market. Every one of those numbers is negotiable. Almost no associate negotiates them.

From the Practice Market Index: as of September 2026, the median dental practice listed for sale collects $957,588 a year, across 753 current listings. See the full index, updated weekly.

The Four Structures That Actually Get Used

Straight cash purchase. You get an outside loan or bring savings, wire the money, and own your percentage on day one. Cleanest structure, highest barrier. The seller gets liquidity, you get voting rights and distributions immediately, and the cap table is unambiguous.

Seller financing. The selling doctor holds a promissory note and you pay them out of distributions over five to ten years. Faster to close, no bank underwriting, no personal guarantee to a third party. The catch is that your partner is also your lender, which means a clinical disagreement in year three is now a disagreement with someone who can accelerate your note.

Shadow account (also called a phantom or bonus-credit account). Instead of writing a check, the practice sets aside a slice of collections in a bookkeeping account credited toward your future equity purchase. Mandelbaum Barrett PC describes the typical set-aside as 1 to 3 percent of net collections, accumulating in lieu of an upfront cash payment. Attractive because it requires no cash at signing. Dangerous because two definitions decide everything: whose collections (yours or the whole practice's), and whether the purchase price is locked at today's valuation or floats to the valuation on the day you finally close. If it floats, you can spend six years funding a stake that got more expensive faster than your account grew.

Earn-in through compensation restructure. Your comp percentage drops, the difference buys equity. Functionally the same as a shadow account with worse optics, because you feel the pay cut every two weeks and the ownership stays abstract.

There's a fifth path that isn't really a buy-in: selling to a group and rolling equity into the parent company. That's a different asset with a different risk profile, and it's become common for a reason. ADA News reports that the share of U.S. dentists affiliated with private equity or DSOs nearly doubled, from 6.6 percent in 2015 to 12.8 percent in 2021, using ADA Health Policy Institute data, with PE-backed transactions climbing from fewer than 20 a year through 2015 to 96 in 2021. That wave matters to you even if you never take a group's call, because it set the price floor your senior partner now believes in.

What Your Equity Is Actually Worth

Practice value runs on adjusted EBITDA, meaning profit after you normalize the owner's clinical compensation to market rate. If the owner has been paying themselves 45 percent of production and calling the rest profit, that's not EBITDA. Restate the doctor comp first, then multiply.

The multiple is a function of size. Sorso, citing FOCUS Investment Banking data from December 2025, puts practices under $2M at 5 to 7 times adjusted EBITDA, $2M to $3M at 7 to 9 times, $3M to $5M at 9 to 11 times, and $5M-plus platform-grade practices at 11 times and up. Three things follow from that curve.

• A single-location practice doing $1.6M is not getting a 10x conversation, no matter what the seller read in a Facebook group.
• If your practice is near a size breakpoint, timing your buy-in before growth crosses the line is worth real money to you and costs your partner real money. Expect that fight.
• Your minority stake is not simply the enterprise value times your percentage. A 20 percent slice with no control and no market to sell into carries a discount. A 20 to 30 percent minority discount is standard practice in valuation work, and if the seller refuses to apply one, they're asking you to pay control price for a non-control position.

One more thing to settle in writing: what the valuation formula will be when you eventually sell. Lock the method now (same multiple band, same EBITDA definition, same discount treatment) or you'll negotiate your exit from the weaker seat.

Operator Math

Take a real-shaped practice. Two doctors, four ops, $2,400,000 in annual collections, and the senior owner is selling 20 percent.

Start with adjusted EBITDA. After restating owner clinical comp to market, the practice runs a 20 percent margin, so adjusted EBITDA is $480,000. At $2.4M in collections the practice sits in the 7 to 9 times band, and a two-doctor single location with PPO-heavy revenue lands at the bottom of it, so use 7 times for an enterprise value of $3,360,000. A straight 20 percent of that is $672,000. Apply a 25 percent minority discount and the defensible price for the stake is $504,000. That $168,000 gap between the two numbers is the single highest-value hour of negotiation in the entire deal.

Now finance it. The British Dental Journal notes that lenders financing a commercial dental practice buy-in typically require a 20 to 25 percent cash deposit, against roughly 10 percent for residential property, with some high-street lenders moving toward 25 percent after the pandemic. At the 25 percent end, your deposit on a $504,000 stake is $126,000 in cash. The remaining $378,000 gets borrowed. At 8 percent over 10 years, the payment is about $4,586 a month, or roughly $55,000 a year in debt service.

What comes back? Your 20 percent of distributable profit is $96,000 a year. Subtract debt service and you net about $40,968 in year one, on top of unchanged clinical compensation. On $126,000 of cash at risk, that's a 32.5 percent cash-on-cash return.

Stress it before you sign it. Say collections hold but margin compresses 15 percent because two hygienists leave and you cover with temps. EBITDA becomes $408,000, your share of distributions drops to $81,600, and after debt service you keep $26,568. Still positive, which is the answer you want. Run the same test at a 25 percent margin hit and see whether the deal goes underwater. If a normal bad year turns your distributions negative against a fixed loan payment, the price is too high or the term is too short.

Compare that to funding the same stake through a shadow account. At 2 percent of the practice's $2.4M in net collections, the account credits $48,000 a year. Reaching $504,000 takes 10.5 years. A decade of waiting, during which you have no vote, no distributions, and no protection if the practice gets sold out from under you. Shadow accounts work for smaller stakes or higher set-aside percentages. For a fifth of a $2.4M practice at 2 percent, the timeline is not a partnership track, it's a retention device.

Vesting, Cliffs, and the Clause That Costs You 25 Percent

Paying for equity and owning equity are different events. Marti Law Group describes a common associate vesting schedule as a five-year vest with a one-year cliff, and notes that "for cause" termination provisions typically let the practice repurchase equity at a discount, for example 75 percent of fair market value.

Read that discount as a dollar figure. If your stake is worth $560,000 at the time of a for-cause termination, a 75 percent buyback pays $420,000. You lose $140,000, and you lose it on the practice's determination of cause.

So the three clauses worth paying a lawyer to fight over are:

• The definition of cause. Narrow it to specifics: loss of license, felony conviction, fraud, a substantiated standard-of-care violation. If the contract says cause includes "conduct detrimental to the practice" with no further definition, that's a discretionary right to claw back your money.
• Who decides. A majority vote of a board your partner controls is not a process. Require a defined standard, written notice, a cure period, and an independent appraiser for FMV.
• What happens in every other exit. Death, disability, retirement, and voluntary departure should each have a named price, a named payment term, and a funding source. Life and disability insurance owned at the entity level is how you keep a buyout from becoming a cash crisis during the worst month of someone's life.

Also pin down the drag-along and tag-along terms. If the majority owner sells to a group, drag-along rights can force you to sell on their terms, and tag-along rights are what guarantee you the same per-unit price they get. Without tag-along protection, your 20 percent can be valued differently than their 80 percent in the same transaction.

The Comp Restructure Nobody Models

The most common post-close surprise has nothing to do with the purchase price. It's that your take-home changes shape. Before the buy-in you earned one number, a percentage of collections or production. After, you earn two: clinical compensation for the dentistry you do, and distributions on the equity you own. Those must be set as separate formulas in separate documents. When they're blended into one "partner draw," the partner who produces more subsidizes the partner who owns more, or the reverse, and within two years somebody feels robbed.

That's backwards. The price is a one-time negotiation. The comp formula runs every payroll for the next twenty years.

Decide these four in writing before closing: how clinical comp is calculated for each owner, who pays for associates and hygiene coverage, how capital expenditures over a set threshold get approved, and what happens to distributions when the practice needs cash. A buy-in is a working capital event for both sides. The seller pulls cash out, the buyer takes on debt, and the practice still has to fund payroll, supplies, and the chair that fails in month four. Fund a reserve before you fund the distribution.

What To Do Before You Sign

• Get a third-party valuation you paid for. A seller-supplied number is an opening bid, not a finding.
• Insist on a quality-of-earnings style look at three years of adjusted EBITDA, including the owner comp normalization. Ask what was added back and why.
• Price the minority discount explicitly. Put the percentage in the term sheet.
• Model debt service against a 15 percent and a 25 percent margin decline. If year one only works in the good case, restructure the term.
• Lock the exit valuation method in the same document as the entry price.
• Have a dental-specific attorney and a dental CPA on your side of the table. Not the practice's attorney. Yours.

The Takeaway

Price the stake off normalized adjusted EBITDA at the multiple your practice size actually supports, then apply a minority discount and put that percentage in writing. Plan for a 20 to 25 percent cash deposit and stress-test the loan payment against a bad year, not an average one, before you commit the deposit. Spend your negotiating energy on the definition of cause, the buyback price in every exit scenario, and tag-along rights, because those clauses decide what your money is worth when the relationship ends. Then set clinical compensation and equity distributions as two separate formulas, in writing, before you close.